2024年中报 | 2023年年报 | 2023年中报 | |
---|---|---|---|
营业收入(元) | |||
胶囊(元) | 401,991,578.96 | 888,029,261.24 | 461,019,147.71 |
颗粒剂、冲剂(元) | 162,125,386.17 | 327,998,864.68 | 191,032,032.83 |
口服液(元) | 544,333,599.47 | 864,350,841.04 | 423,263,604.24 |
凝胶剂(元) | 21,400,637.22 | 23,554,574.16 | 10,295,333.27 |
片丸剂(元) | 168,996,406.52 | 350,529,511.35 | 178,190,427.31 |
贴剂(元) | 103,675,861.48 | 211,005,843.59 | 116,411,920.36 |
注射剂(元) | 840,079,148.81 | 2,174,063,893.59 | 1,158,559,777.49 |
营业成本(元) | |||
胶囊(元) | 122,130,897.66 | 286,986,167.28 | 149,672,328.32 |
颗粒剂、冲剂(元) | 39,623,016.02 | 78,421,582.20 | 40,542,961.93 |
口服液(元) | 115,420,813.54 | 161,764,205.33 | 80,001,980.80 |
凝胶剂(元) | 2,549,534.75 | 3,233,651.46 | 1,298,013.47 |
片丸剂(元) | 46,920,182.30 | 95,041,950.06 | 49,815,520.51 |
贴剂(元) | 21,513,829.60 | 36,797,144.36 | 18,902,356.39 |
注射剂(元) | 217,089,584.63 | 573,374,526.89 | 291,950,082.43 |
毛利(元) | |||
胶囊(元) | 279,860,681.30 | 601,043,093.96 | 311,346,819.39 |
颗粒剂、冲剂(元) | 122,502,370.15 | 249,577,282.48 | 150,489,070.90 |
口服液(元) | 428,912,785.93 | 702,586,635.71 | 343,261,623.44 |
凝胶剂(元) | 18,851,102.47 | 20,320,922.70 | 8,997,319.80 |
片丸剂(元) | 122,076,224.22 | 255,487,561.29 | 128,374,906.80 |
贴剂(元) | 82,162,031.88 | 174,208,699.23 | 97,509,563.97 |
注射剂(元) | 622,989,564.18 | 1,600,689,366.70 | 866,609,695.06 |
毛利率(%) | |||
胶囊(%) | 69.62 | 67.68 | 67.53 |
颗粒剂、冲剂(%) | 75.56 | 76.09 | 78.78 |
口服液(%) | 78.80 | 81.28 | 81.10 |
凝胶剂(%) | 88.09 | 86.27 | 87.39 |
片丸剂(%) | 72.24 | 72.89 | 72.04 |
贴剂(%) | 79.25 | 82.56 | 83.76 |
注射剂(%) | 74.16 | 73.63 | 74.80 |
收入构成(%) | |||
胶囊(%) | 17.93 | 18.35 | 18.16 |
颗粒剂、冲剂(%) | 7.23 | 6.78 | 7.52 |
口服液(%) | 24.27 | 17.86 | 16.67 |
凝胶剂(%) | 0.95 | 0.49 | 0.41 |
片丸剂(%) | 7.54 | 7.24 | 7.02 |
贴剂(%) | 4.62 | 4.36 | 4.59 |
注射剂(%) | 37.46 | 44.92 | 45.63 |
毛利构成(%) | |||
胶囊(%) | 16.68 | 16.68 | 16.33 |
颗粒剂、冲剂(%) | 7.30 | 6.93 | 7.89 |
口服液(%) | 25.57 | 19.50 | 18.00 |
凝胶剂(%) | 1.12 | 0.56 | 0.47 |
片丸剂(%) | 7.28 | 7.09 | 6.73 |
贴剂(%) | 4.90 | 4.83 | 5.11 |
注射剂(%) | 37.14 | 44.42 | 45.45 |